| Biomarker ID | 1999 |
| PMID | 22589488 |
| Year | 2012 |
| Biomarker | Methylation status of ZNF135 |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Differentially Methylated in Clinical recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Clinical recurrence vs. biochemical recurrence |
| Type of Biomarker | Prognostic |
| Cohort | clinical recurrence (n = 80) versus biochemical recurrence (n = 43) |
| Senstivity | Training: 59.3 (45.7–71.9); validation: 50.0 (27.2–72.8) |
| Specificity | Training: 61.5 (44.6–76.6); validation: 50.0 (27.2–72.8) |
| AUC | Training: 0.66; validation: 0.56 |
| Accuracy | NA |
| Level Of Significance | <0.0061 |
| Method Used | Pyrosequencing |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | ZNF135 |